Quantum Computing Inc. Applies Optimization and AI to XPro Research

INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer's drug research and explore new applications for XPro

Boca Raton, Florida, October 14th, 2026, Financewire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro. Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development. INmune Bio Inc. (Nasdaq: INMB) […] This story cont…

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro ™

Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XProInitial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to…

Quantum Computing Inc. Applies Optimization and AI to XPro Research

The Stage 1 engagement will analyze preclinical work, data from four clinical trials and public biomedical datasets to seek patient biomarkers and possible new uses for INmune Bio, Inc.’s drug candidate.

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro

Boca Raton, Florida, 14th October 2026, FinanceWire

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro - News Direct

Boca Raton, Florida, 14th October 2026, NewsDirect